Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Winfred Woodrow Williams Jr., M.D.

Co-Author

This page shows the publications co-authored by Winfred Williams and A. Cosimi.
Connection Strength

0.611
  1. A prospective, randomized, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric renal transplant recipients. Transplantation. 2003 Sep 15; 76(5):798-802.
    View in: PubMed
    Score: 0.069
  2. Haploidentical hematopoietic cell and kidney transplantation for hematological malignancies and end-stage renal failure. Blood. 2019 07 11; 134(2):211-215.
    View in: PubMed
    Score: 0.051
  3. The clinical usefulness of the renal allograft biopsy in the cyclosporine era: a prospective study. Transplantation. 1999 Mar 15; 67(5):737-41.
    View in: PubMed
    Score: 0.050
  4. Anticardiolipin antibodies and hepatic artery thrombosis after liver transplantation. Transplantation. 1997 Nov 15; 64(9):1361-4.
    View in: PubMed
    Score: 0.046
  5. Nephrotic syndrome after liver transplantation in a patient with hepatitis C virus-associated glomerulonephritis. Transplantation. 1997 Oct 15; 64(7):1073-6.
    View in: PubMed
    Score: 0.046
  6. Management of the renal allograft recipient: immunosuppressive protocols for long-term success. Clin Transplant. 1994 Feb; 8(1):34-9.
    View in: PubMed
    Score: 0.035
  7. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med. 2008 Jan 24; 358(4):353-61.
    View in: PubMed
    Score: 0.023
  8. Cardiovascular risk profile after conversion from cyclosporine A to tacrolimus in stable renal transplant recipients. Transplantation. 2004 Apr 27; 77(8):1199-202.
    View in: PubMed
    Score: 0.018
  9. Reproductive and contraceptive characteristics of premenopausal kidney transplant recipients. Prog Transplant. 2003 Sep; 13(3):193-6.
    View in: PubMed
    Score: 0.017
  10. A prospective, randomized clinical trial of cyclosporine reduction in stable patients greater than 12 months after renal transplantation. Transplantation. 2003 May 15; 75(9):1501-5.
    View in: PubMed
    Score: 0.017
  11. Acute humoral rejection in hepatitis C-infected renal transplant recipients receiving antiviral therapy. Am J Transplant. 2003 Jan; 3(1):74-8.
    View in: PubMed
    Score: 0.016
  12. Remission of hepatitis C virus-associated cryoglobulinemic glomerulonephritis with interferon alfa-2b and ribavirin combination therapy after liver transplantation. Transplantation. 2002 Dec 27; 74(12):1767-8.
    View in: PubMed
    Score: 0.016
  13. Tacrolimus-associated posttransplant diabetes mellitus in renal transplant recipients: role of hepatitis C infection. Transplant Proc. 2002 Aug; 34(5):1771-73.
    View in: PubMed
    Score: 0.016
  14. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol. 2002 Mar; 13(3):779-787.
    View in: PubMed
    Score: 0.015
  15. Managing the highly sensitized transplant recipient and B cell tolerance. Curr Opin Immunol. 2001 Oct; 13(5):577-81.
    View in: PubMed
    Score: 0.015
  16. Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection. Transplantation. 2001 Jul 15; 72(1):77-83.
    View in: PubMed
    Score: 0.015
  17. Complement activation products in plasma after heart transplantation in humans. Transplantation. 2001 May 15; 71(9):1308-11.
    View in: PubMed
    Score: 0.015
  18. Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics. Transplantation. 2001 Mar 15; 71(5):652-8.
    View in: PubMed
    Score: 0.014
  19. Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J Am Soc Nephrol. 2001 Mar; 12(3):574-582.
    View in: PubMed
    Score: 0.014
  20. Renal disease associated with hepatitis C infection after kidney and liver transplantation. Transplantation. 2000 Jul 27; 70(2):255-61.
    View in: PubMed
    Score: 0.014
  21. Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries. J Am Soc Nephrol. 1999 Oct; 10(10):2208-14.
    View in: PubMed
    Score: 0.013
  22. In vivo generation of C4d, Bb, iC3b, and SC5b-9 after OKT3 administration in kidney and lung transplant recipients. Transplantation. 1999 Jan 27; 67(2):253-8.
    View in: PubMed
    Score: 0.012
  23. Renal thrombotic microangiopathy associated with anticardiolipin antibodies in hepatitis C-positive renal allograft recipients. J Am Soc Nephrol. 1999 Jan; 10(1):146-53.
    View in: PubMed
    Score: 0.012
  24. Rapid activation of the alternative pathway of complement by extracorporeal membrane oxygenation. ASAIO J. 1999 Jan-Feb; 45(1):113-4.
    View in: PubMed
    Score: 0.012
  25. Plasma exchange and tacrolimus-mycophenolate rescue for acute humoral rejection in kidney transplantation. Transplantation. 1998 Dec 15; 66(11):1460-4.
    View in: PubMed
    Score: 0.012
  26. Chronic rejection and chronic cyclosporin toxicity in renal allografts. Immunol Today. 1998 Nov; 19(11):514-9.
    View in: PubMed
    Score: 0.012
  27. De novo collapsing glomerulopathy in renal allografts. Transplantation. 1998 May 15; 65(9):1192-7.
    View in: PubMed
    Score: 0.012
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.